SCHEMBL19612760

SCHEMBL19612760

O=C(Cl)CCCCCc1ccc2ccccc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 4/20 0.68
▸ HDAC8 Q9BY41 4/20 0.68
▸ CYP1A2 P05177 2/20 0.64
▸ NAAA Q02083 1/20 0.56
▸ HCAR2 Q8TDS4 1/20 0.54
▸ SIGMAR1 Q99720 1/20 0.49
▸ HDAC3 O15379 3/20 0.48
▸ HDAC2 Q92769 3/20 0.48
▸ PDPK1 O15530 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ MAPT P10636 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.46
▸ SLC13A5 Q86YT5 1/20 0.44
▸ HDAC4 P56524 1/20 0.44
▸ HDAC7 Q8WUI4 1/20 0.44
▸ HDAC10 Q969S8 1/20 0.44
▸ HDAC11 Q96DB2 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.44
▸ HDAC9 Q9UKV0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9062915 1.00 HDAC1 (0.68) HDAC1HDAC8CYP1A2NAAAHCAR2
SCHEMBL16898315 0.93 CYP1A2 (0.73) HDAC1HDAC8CYP1A2NAAAHCAR2
SCHEMBL7191582 0.86 CYP1A2 (0.62) HDAC1HDAC8CYP1A2HCAR2SIGMAR1
SCHEMBL10439755 0.85 CYP1A2 (0.87) HDAC1HDAC8CYP1A2NAAAHCAR2
SCHEMBL2536989 0.85 CYP1A2 (0.87) HDAC1HDAC8CYP1A2NAAAHCAR2
SCHEMBL8434872 0.85 CYP1A2 (0.87) HDAC1HDAC8CYP1A2NAAAHCAR2
SCHEMBL10439522 0.85 CYP1A2 (0.87) HDAC1HDAC8CYP1A2NAAAHCAR2
SCHEMBL10439619 0.85 CYP1A2 (0.87) HDAC1HDAC8CYP1A2NAAAHCAR2
SCHEMBL710798 0.85 CYP1A2 (0.87) HDAC1HDAC8CYP1A2NAAAHCAR2
SCHEMBL2107915 0.85 CYP1A2 (0.87) HDAC1HDAC8CYP1A2NAAAHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10174015-B2 Substituted heterocyclic derivative, preparation method and use thereof XIAMEN UNIVERSITY (CN) 2019-01-08 — — US disclosed
US-20170334896-A1 Substituted Heterocyclic Derivative, Preparation Method And Use Thereof XIAMEN UNIVERSITY (CN) 2017-11-23 — — US disclosed
CN-107074788-A Substituted heterocyclic derivatives, preparation method and application thereof 厦门大学 2017-08-18 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334896-A1 Substituted Heterocyclic Derivative, Preparation Method And Use Thereof FAAH, NAAA, FAAH2 HDAC1 317/4885HDAC8 522/4885CYP1A2 286/4885
US-10174015-B2 Substituted heterocyclic derivative, preparation method and use thereof DHPS, CYP3A5, CYP3A4 HDAC1 646/4885HDAC8 667/4885CYP1A2 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback